Pancreatitis and pancreatic cancer in patients with type 2 diabetes treated with glucagon-like peptide-1 receptor agonists: an updated meta-analysis of randomized controlled trials.
CONCLUSIONS: No clear evidence of risk for pancreatitis was observed, whereas data on pancreatic cancer are too scarce to draw any conclusion.
PMID: 32720500 [PubMed - as supplied by publisher]
Source: Minerva Endocrinologica - Category: Endocrinology Tags: Minerva Endocrinol Source Type: research
More News: Byetta | Cancer | Cancer & Oncology | Cardiology | Cardiovascular | Clinical Trials | Diabetes | Diabetes Type 2 | Endocrinology | Heart | Pancreas | Pancreatic Cancer | Pancreatitis | Victoza